India
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 362.26 M
|
March 31, 2024 | USD 13.57 | -0.25% |
|
India |
|
2 |
USD 143.39 M
|
March 31, 2024 | USD 18.21 | -3.37% |
|
India |
|
3 |
USD 83.02 M
|
March 31, 2024 | USD 17.54 | 2.44% |
|
India |
|
4 |
USD 30.46 M
|
March 31, 2024 | USD 25.14 | -2.56% |
|
India |
|
5 |
USD 30.41 M
|
March 31, 2024 | USD 21.37 | -1.96% |
|
India |
|
6 |
USD 11.22 M
|
March 31, 2024 | USD 4.72 | -3.66% |
|
India |
|
7 |
USD 3.15 M
|
March 31, 2024 | USD 11.74 | -1.33% |
|
India |
The Vaccines company in India with the highest Total Non-Current Liabilities is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at USD 362.26 M.
The Vaccines company in India with the lowest Total Non-Current Liabilities is Vimta Labs Limited (NSE: VIMTALABS.NS) at USD 3.15 M.
The top 10 Vaccines companies in India by Total Non-Current Liabilities are Aurobindo Pharma Limited, Wockhardt Limited, Glenmark Pharmaceuticals Limited, GlaxoSmithKline Pharmaceuticals Limited, Hester Biosciences Limited, Panacea Biotec Limited and Vimta Labs Limited.
The bottom 10 Vaccines companies in India by Total Non-Current Liabilities are Vimta Labs Limited, Panacea Biotec Limited, Hester Biosciences Limited, GlaxoSmithKline Pharmaceuticals Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited and Aurobindo Pharma Limited.